Infectious Disease
RSSArticles
-
CDC Drafts Infection Control Guidelines for Staph in NICUs
The Centers for Disease Control (CDC) has issued draft guidelines to prevent invasive Staphylococcus aureus infections in neonatal intensive care units (NICUs). -
ID Groups Demand Border Patrol Give Detainees Flu Shots
The U.S. Customs and Border Protection’s (CBP) decision to not vaccinate migrants in detention facilities against flu and other infections is being slammed by leading clinicians and public health officials. -
Sepsis Can Begin With a Single Infection
The goal of antibiotic stewardship is to stop unnecessary use, but for those with sepsis, a critical step is to assess antibiotic therapy 48 to 72 hours after initiation.
-
IPs Playing Critical Role in Antibiotic Stewardship
Infection preventionists (IPs) are playing key roles in antibiotic stewardship programs, which are now in place in most U.S. hospitals and making some hard-earned progress against a horde of multidrug-resistant bacteria. -
Darolutamide Tablets (Nubeqa)
Darolutamide should be prescribed to patients with nonmetastatic, castration-resistant prostate cancer.
-
Carpal Tunnel Syndrome in the Extreme Elderly
Carpal tunnel syndrome (CTS), when seen in the very elderly, usually is severe and is not reliably diagnosed by ultrasound. Nerve conduction studies and electromyography are the most sensitive and specific tests to make accurate diagnosis of CTS.
-
No Antibiotic Prescription Required
Acquisition of antibiotics without a prescription can be easy in the United States.
-
CRP and Reduction of Antibiotic Use in Acute Exacerbations of COPD
Point-of-care C-reactive protein testing can safely and effectively reduce antibiotic use in patients with acute exacerbations of COPD.
-
Treating Infective Endocarditis in Moderate-Risk Patients
There are patients with a moderate risk of infective endocarditis who may warrant consideration of antibiotic prophylaxis.
-
Calcitonin Gene-Related Peptide Targeting Therapies for Migraine
Two randomized clinical trials showed that calcitonin gene-related peptide targeting therapies are effective and safe for primary headache disorders.